Help ASH Build an Inclusive Hematology Community!
ASH is committed to building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences as it works toward one collective goal: helping hematologists conquer blood diseases worldwide.
How Can You Help?
Visit your My Account page, make needed updates to your demographic details, and select your preferred level of ASH access to your information; aggregated or individually identifiable, or choose not to provide or share your information. By sharing information about who you are, you will help ASH have a better appreciation of the diverse needs and talents present in the field, and help to build a more inclusive, collaborative hematology community. It will take only a few moments to complete!
Update Access to Demographic Information Learn About Our MissionASH publications include both clinical and scientific research, and education in the field of hematology.
Journals
With an Impact Factor of 21.0, Blood is the most cited peer-reviewed publication in the field of hematology with over 168,000 citations in 2023. It is the premier journal of the American Society of Hematology and since 1946 it has provided an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology.
Current Issue | Archives | Blood Podcast | Submit
International Editions: Chinese | Italian | Latin America | Spanish
Blood Advances is ranked among the top 10 most cited hematology journals, and it publishes more peer-reviewed hematology research than any other scientific journal worldwide. It is an open access, online-only journal that publishes articles covering all aspects of hematology, including original research and important community resources such as the ASH Clinical Guidelines.
Blood Neoplasia is an open access, online-only journal that publishes original research on hematologic malignancies and associated disorders, including leukemia, lymphoma, multiple myeloma, Waldenström macroglobulinemia, hemophagocytic lymphohistiocytosis, myeloproliferative neoplasms, measurable residual disease, and precursor conditions.
Blood Vessels, Thrombosis & Hemostasis focuses on clinical and mechanistic aspects of normal and abnormal hemostasis and vascular function, including acquired bleeding and thrombotic disorders. Other topics published in this open access, online-only journal include disorders involving the venous, arterial, and microvasculature.
Blood Global Hematology publishes local adaptions of clinical guidelines, epidemiology and public health analyses, and opinion articles that address hematologic issues of global impact. This open access, online-only journal aims to improve the lives of patients worldwide. Blood Global Hematology provides a supportive publication experience for authors, particularly those from regions currently underrepresented in medical literature.
Blood Red Cells & Iron welcomes articles with significant clinical and/or scientific impact on the topics of red blood cells and research relevant to hematologic diseases involving erythroid lineage. Other topics in this open access, online-only journal include inherited and acquired anemias, nutritional anemias, sickle cell disease, thalassemia, malaria, immune-mediated anemias, and normal and many other topics.
Blood Immunology & Cellular Therapy focuses on research in basic, translational, and clinical investigations related to cellular and non-cellular immunotherapies for hematological conditions and the underlying immunology. The scope of this open access, online-only journal includes non-cellular therapies like vaccinations, monoclonal antibodies, antibody-drug conjugates, and immune checkpoint inhibitors, and gene therapies.
Other Publications
ASH’s bimonthly member newsletter, The Hematologist: ASH News and Reports, is designed for the broad constituency of ASH, ranging from basic scientists to practicing clinicians. The Hematologist updates readers about important breakthroughs, trials, and literature; publishes expert advice for clinicians; and spotlights the latest ASH programs and initiatives.
ASH Clinical News, a monthly news magazine specifically designed to appeal to clinical practitioners in hematology and oncology, provides timely updates in the field by reporting on key medical meetings, clinical trials, innovative technology, and influential papers in the literature. Regular features include clinical consults, interviews with leaders in various hematology subspecialties, patient education information, news about individual ASH members, and updates on Society initiatives.
The official newspaper of the ASH annual meeting, ASH News Daily highlights each day’s sessions and events.
Educational Resources
Hematology, ASH Education Program
Hematology, the ASH Education Program, provides in-depth chapters covering each session presented in the ASH annual meeting Education Program.
ASH Self-Assessment Program
The ASH-SAP is a high-quality educational product offering up-to-date information in the field of hematology for internists, hematologists, pediatricians, and hematology-oncology fellows.
How I Treat - A Compendium for the Practicing Hematologist
This compendium features 33 How I Treat articles published in Blood, which have been reviewed and updated to reflect the most recent scientific and clinically relevant information that has come to light since the articles were first published.